Preclinical models of hepatosplenic γδ T-cell lymphoma with an activating STAT5B mutation display sensitivity to JAK inhibitor upadacitinib

Autor:in

Aung, Myint Myat Khine; Schönefeldt, Susann; Pfalz‐Kraupp, Sophie; Wais, Tamara; Suske, Tobias; Zahma, Safia; Franz, Stefan; Müllebner, Andrea; Feurstein, Gabriela; Wagner, Christina; Eder, Thomas; Pemovska, Tea; Agreiter, Christiane; Pichler, Alexander; Staber, Philipp B.; Hofer, Martin; Steinborn, Ralf; Strohmer, Svenja‐Verena; Simonitsch‐Klupp, Ingrid; Bauer, Marcus; Wilfer, Andreas; Weber, Thomas; Potdar, Swapnil; Aittokallio, Tero; Jungherz, Dennis; Müller, Tony A.; List, Julia; Gotthardt, Dagmar; Grebien, Florian; Bekiaris, Vasileios; Herling, Marco; Moriggl, Richard; Neubauer, Heidi A.

Journal

HemaSphere

CC Lizenz

CC-BY

DOI

10.1002/hem3.70345

PubMed ID

42007450